Hsu CY - Search Results

1

Genomic Alterations of Tumors in HER2-Low Breast Cancers.

Tsai YF, Huang CC, Hsu CY, Feng CJ, Lin YS, Chao TC, Lai JI, Lien PJ, Liu CY, Chiu JH, Tseng LM. Tsai YF, et al. Among authors: hsu cy. Int J Mol Sci. 2024 Jan 21;25(2):1318. doi: 10.3390/ijms25021318. Int J Mol Sci. 2024. PMID: 38279318 Free PMC article.

2

Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer.

Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW, Lee LM, Wei YH, Lee HC. Tseng LM, et al. Among authors: hsu cy. Genes Chromosomes Cancer. 2006 Jul;45(7):629-38. doi: 10.1002/gcc.20326. Genes Chromosomes Cancer. 2006. PMID: 16568452

3

Invasive ductal carcinoma arising in phyllodes tumor with isolated tumor cells in sentinel lymph node.

Kuo YJ, Ho DM, Tsai YF, Hsu CY. Kuo YJ, et al. Among authors: hsu cy. J Chin Med Assoc. 2010 Nov;73(11):602-4. doi: 10.1016/S1726-4901(10)70131-3. J Chin Med Assoc. 2010. PMID: 21093830 Free article. Review.

4

Somatic mutations of the mitochondrial genome in human breast cancers.

Tseng LM, Yin PH, Yang CW, Tsai YF, Hsu CY, Chi CW, Lee HC. Tseng LM, et al. Among authors: hsu cy. Genes Chromosomes Cancer. 2011 Oct;50(10):800-11. doi: 10.1002/gcc.20901. Epub 2011 Jul 11. Genes Chromosomes Cancer. 2011. PMID: 21748819

5

Rab5A is associated with axillary lymph node metastasis in breast cancer patients.

Yang PS, Yin PH, Tseng LM, Yang CH, Hsu CY, Lee MY, Horng CF, Chi CW. Yang PS, et al. Among authors: hsu cy. Cancer Sci. 2011 Dec;102(12):2172-8. doi: 10.1111/j.1349-7006.2011.02089.x. Epub 2011 Oct 18. Cancer Sci. 2011. PMID: 21895870 Free article.

6

ROCKII Ser1366 phosphorylation reflects the activation status.

Chuang HH, Yang CH, Tsay YG, Hsu CY, Tseng LM, Chang ZF, Lee HH. Chuang HH, et al. Among authors: hsu cy. Biochem J. 2012 Apr 1;443(1):145-51. doi: 10.1042/BJ20111839. Biochem J. 2012. PMID: 22273145

7

Sonographic presentations of metaplastic breast cancers.

Lai YC, Hsu CY, Chou YH, Tiu CM, Tseng LM, Wang HK, Chiou HJ. Lai YC, et al. Among authors: hsu cy. J Chin Med Assoc. 2012 Nov;75(11):589-94. doi: 10.1016/j.jcma.2012.08.005. Epub 2012 Oct 9. J Chin Med Assoc. 2012. PMID: 23158037 Free article.

8

Adjust cut-off values of immunohistochemistry models to predict risk of distant recurrence in invasive breast carcinoma patients.

Chen YY, Tseng LM, Yang CF, Lien PJ, Hsu CY. Chen YY, et al. Among authors: hsu cy. J Chin Med Assoc. 2016 Dec;79(12):649-655. doi: 10.1016/j.jcma.2016.06.004. Epub 2016 Aug 29. J Chin Med Assoc. 2016. PMID: 27595437 Free article.

9

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.

Chiu JH, Wen CS, Wang JY, Hsu CY, Tsai YF, Hung SC, Tseng LM, Shyr YM. Chiu JH, et al. Among authors: hsu cy. J Transl Med. 2017 May 4;15(1):97. doi: 10.1186/s12967-017-1192-x. J Transl Med. 2017. PMID: 28472954 Free PMC article.

10

Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.

Tsai YF, Tseng LM, Hsu CY, Yang MH, Chiu JH, Shyr YM. Tsai YF, et al. Among authors: hsu cy. PLoS One. 2017 Jun 12;12(6):e0178173. doi: 10.1371/journal.pone.0178173. eCollection 2017. PLoS One. 2017. PMID: 28604807 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,952 results

Search Page